Companies ›Healthcare ›BVS.HN

BVS.HN — — Diversified Medical Equipment & Supplies

Bvs.Hn

$26 000,00

Open in Charts → Attach watcher ⌖

— —

USD

Set alert

Last 30 days

1D5D1M3M6MYTD1Y5YMax

Live price chart loads from the market-data widget.

Mcap

—

P/E

—

EV / Rev

—

Div yield

3,12 %

Op margin

24,1 %

ROE

8,5 %

Net margin

20,4 %

Debt / equity

1,53

Beta

—

52w range

—

Volume

512

Day range

$8,88–$9,16

Prev close

$9,02

Open

$9,05

Next earnings

2026-10-28

Ex-dividend

—

TR 1Y

—

About

BVS.HN operates in the investment banking and brokerage services sector, generating revenue primarily through financial advisory, asset management, and trading activities.

Business. Bioventus Inc (BVS.O) is a healthcare services and equipment company operating in the medical equipment, supplies, and distribution industry. The firm generates revenue primarily through the sale of products, including medical devices and consumables. Bioventus is headquartered in the United States and is listed on the NASDAQ stock exchange. Specific details regarding its operating segments and geographic revenue mix are not provided in the available data.

Classification99 %

SectorHealth Care

Industry groupDiversified Medical Equipment & Supplies

Generated · model-assisted

Sell-side consensus

—consensus pending

— buy— hold— sell

Avg 12m price target—

Upcoming events

EarningsQ3 2026 earnings (expected)2026-10-28 · estimated

See all catalysts →

At a glance

Score

—

not yet scored

Valuation

—

valuation pending

Analysts

—

not yet wired

Ownership→

American Century Investment Management, Inc.

largest disclosed fund holder

Profitability→

8,5 %

return on equity

Quality

—

not yet scored

What drives this business

The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.

— missing data

News & coverage

No recent newsroom coverage mentioning BVS.

Sector rotation

Sector1D1Mvs mkt

Materials+2,3 %+6,6 %+1,7 %

Communication Services+2,2 %−5,5 %+1,6 %

Energy+0,6 %+3,3 %+0,0 %

Health Care · THIS SECTOR+0,6 %−0,8 %+0,0 %

Information Technology+0,6 %+6,7 %+0,0 %

Consumer Discretionary+0,4 %+7,6 %−0,2 %

Financials−0,3 %−2,8 %−0,9 %

Consumer Staples−0,4 %+2,5 %−1,0 %

Real Estate−0,7 %+10,9 %−1,3 %

Industrials−1,9 %−3,1 %−2,5 %

Utilities−1,9 %+28,2 %−2,5 %

Developing storylines

No tracked sagas currently linked to BVS.HN. Browse all sagas →

Analysis

AI analysis

Generated · analysis pipeline · tier hybrid · as of 2026-08-04 ↑ At a glance

Opportunity

— missing data

Upcoming catalysts

Scheduled public events. Informational only — not investment advice.

Company
EarningsQ3 2026 earnings (expected)2026-10-28 · estimated
Macro
Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
Rate decisionEuropean Central Bank rate decision (press conf.)2026-09-10 · EU
Macro & political
ElectionSE Swedish Election2026-09-14 · SE
ElectionUS U.S. Midterms2026-11-03 · US
ElectionFR French Legislative2027-06-01 · FR

Pre-earnings brief

— missing data

Signals & dispatch

peak dispatch · —

Composite-score breakdown

Synthesis

Business

Bioventus Inc (BVS.O) is a healthcare services and equipment company operating in the medical equipment, supplies, and distribution industry. The firm generates revenue primarily through the sale of products, including medical devices and consumables. Bioventus is headquartered in the United States and is listed on the NASDAQ stock exchange. Specific details regarding its operating segments and geographic revenue mix are not provided in the available data.

Classification99 %

SectorHealth Care

Industry groupDiversified Medical Equipment & Supplies

AI synthesis

GENERATED

BVS.HN maintains a capital structure with a debt-to-equity ratio of 1.53, indicating a moderate reliance on debt financing. The company's liquidity position is assessed as medium, with a current ratio of 1.5, suggesting it can cover short-term obligations but with limited buffer. The negative net cash position after subtracting total debt highlights a potential liquidity constraint.

Profitability metrics show a return on equity (ROE) of 8.45% and a return on assets (ROA) of 3.19%. These figures are below the industry median for ROE and ROA, indicating that BVS.HN is underperforming its peers in terms of capital efficiency and asset utilization.

The company's revenue is concentrated in a single business segment, with no disclosed geographic diversification. This lack of diversification increases exposure to sector-specific risks and regional economic fluctuations.

BVS.HN's growth trajectory is mixed. While the company reported a net income of 224.5 billion VND, its operating cash flow was negative at -674.6 billion VND, signaling potential operational inefficiencies or capital outflows. The outlook for the current fiscal year shows a modest revenue increase, but the next fiscal year is expected to see a decline in revenue growth.

Risk factors include a medium liquidity risk due to the current ratio and negative net cash position. The dilution risk is assessed as low, with no significant dilution potential in the near term. However, the company's reliance on debt financing and negative operating cash flow could pose long-term financial risks.

Recent filings and transcripts indicate that BVS.HN is focusing on cost optimization and digital transformation to improve operational efficiency. The company has also been expanding its asset management services to diversify revenue streams.

Key takeaways

BVS.HN's debt-to-equity ratio of 1.53 indicates a moderate reliance on debt financing.
The company's ROE of 8.45% and ROA of 3.19% are below industry medians, suggesting underperformance in capital efficiency.
Revenue is concentrated in a single business segment, increasing exposure to sector-specific risks.
Negative operating cash flow and a medium liquidity risk highlight potential operational and financial constraints.
The company is pursuing cost optimization and digital transformation to improve efficiency and diversify revenue.

Bull / Bear case

Generated · model-assisted

— missing data

In focus — financials by report

Valuation

Market price

$26 000,00

Market cap

—

Enterprise valueⓘ

—

P/Eⓘ

—

Non-GAAP P/Eⓘ

—

EV / Revenueⓘ

—

EV / Op incomeⓘ

—

EV / OCFⓘ

—

P / Bⓘ

—

P / Tangible bookⓘ

—

Tangible book

$2.66T

Net cashⓘ

-$4.07T

Current ratioⓘ

1.5

Debt / equityⓘ

1.5

ROAⓘ

3.2%

ROEⓘ

8.5%

Cash conversionⓘ

-300.0%

CapEx / revenueⓘ

-0.8%

SBC / revenueⓘ

—

Dilution ratioⓘ

0.0%